Preliminary trial of 9-hydroxy-2-methyl ellipticinium (NSC 264--137) in advanced human cancers.
D000470:Alkaloids / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004611:Ellipticines / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D012075:Remission, Spontaneous
D000470:Alkaloids; D004611:Ellipticines